A two-stage transdermal drug delivery system comprising sono-phase-change transfersomes for non-invasive deep dermal delivery
Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation
Prenatal arsenic exposure disrupts placental angiogenesis by altering Pdgfb promoter epigenetic modification